Delivery Order SPE2DB22D9155-SPE2DB25FSHY4

Award Date 4/4/25
Potential Completion Date 4/7/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a firm fixed-price delivery order valued at $1,522.40. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division for the supply of PROTOPAM CHLORIDE 1 GM VIALS. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that specializes in providing a wide range of pharmaceutical products and medical supplies to the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $4,311.35 and has an ultimate completion date of April 19, 2024. The contract is part of the DLA's Medical Supply Chain program and is issued under a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. Under this IDC, DMS...
This is a firm-fixed price delivery order for pharmaceutical products awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract award has a ceiling value of $1,627.06 and an ultimate completion date of July 15, 2024. DMS Pharmaceutical Group is the prime contractor and there is no set-aside designation mentioned. The contract provides a wide range of pharmaceutical items, including both...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,254.93, is for the delivery of atovaquone and progesterone pharmaceutical products to support the medical supply needs of military health facilities. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $14,589.20, is for the delivery of pharmaceutical products to support the DLA's Medical Supply Chain program. The contract has an ultimate completion date of May 15, 2025 and was awarded on May 8, 2025. The contract is not set aside and allows DMS Pharmaceutical Group to compete effectively as a woman-owned...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, worth up to $35,995.42, has a completion date of July 2, 2024 and is not set aside. DMS Pharmaceutical Group provides a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities and VA medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,850.28 contract has an ultimate completion date of March 26, 2025 and covers the provision of a range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,264.32, is for the Prime Vendor Pharmaceutical program supporting the DLA's Medical Supply Chain division. DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at $1,690.47 and has an ultimate completion date of October 2, 2024. The contract is for the delivery of pharmaceutical products, including prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The firm fixed-price contract is valued at $41,103.40 and has an ultimate completion date of March 28, 2025. The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure this direct federal award. DMS Pharmaceutical Group holds a larger...
  • SPE2DB22D9155
    Indefinite Delivery Contract
  • SPE2DB22D9155-SPE2DB25FSHY4
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 1 gram vials of Protopam Chloride, a specialized pharmaceutical product, with a ceiling value of $1,559.52 and a completion date of April 7, 2025.

DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The contract award is not associated with any set-aside designation, which allows DMS Pharmaceutical Group Inc. to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 7/4/25, 11:27 AM